Interview in French with Marc Doyer, who argues that newly published Pfizer contracts and recent public statements by pro-vaccine doctors/politicians expose deception, poor consent, and a lack of long-term safety data disclosure. The conversation is less about trading and more about the Covid vaccine controversy, legal action, and Doyer’s personal campaign and reconstruction projects.
Watch on YouTube ›Get the market thesis, key claims, assets, contradictions, and follow-up questions from any financial video — then unlock a version personalized to your portfolio, watchlist, and favorite speakers.
This is a talk-show style interview on Tocsin with host Clémence and guest Marc Doyer, identified as spokesperson for Verity France. The discussion centers on Doyer’s claims that he and others receive insults and threats after criticizing Covid vaccination policy, especially following the publication of Pfizer contracts and public attacks from figures such as former health minister Aurélien Rousseau and doctors Jerome Marty and Lamarque. Doyer argues that these people are accusing critics of being dangerous or anti-vax despite, in his view, having previously promoted vaccines like AstraZeneca and making claims about Covid vaccines without properly disclosing uncertainty around efficacy and long-term side effects. A major theme is informed consent: Doyer repeatedly says he would have refused vaccination if he had been told that efficacy was uncertain and long-term side effects were …
Near term, the setup is continued controversy: newly released Pfizer material and social-media attacks on critics are likely to trigger more backlash and more legal posturing. The immediate risk is that the segment’s claims spread faster than the evidence supporting their interpretation.
Over the next several weeks or months, the transcript expects the contract disclosures to keep validating the guest’s consent-and-liability thesis and to feed court actions. That view would be weakened if the documents are interpreted as less revealing than portrayed or if the legal process does not move the narrative forward.
The long-run implication is not about one vaccine product but about institutional trust, emergency health governance, and consent standards. If this interpretation persists, the broader regime shift is toward greater skepticism of official public-health messaging and more litigation after mass vaccination campaigns.
Marc Doyer says he is receiving threats and insults, but that this is not new.
He states that threats and insults have existed for some time and that the current wave is part of a broader pattern.
He says doctors such as Jérôme Marty are publicly urging authorities to come after anti-vaccine activists and investigate them.
He quotes Marty as saying authorities should act against 'meneurs antivax' and that not doing so means supporting them.
Doyer argues that critics of anti-vaccine activists are themselves guilty of misinformation because they praised vaccines that later proved problematic.
He says Marty praised AstraZeneca, and that the same vaccine was later withdrawn by authorities for major problems.
Quelle est cette histoire de menace que vous recevez Marc Doyer ?
Doyer says threats and insults have existed for a long time, but that the current wave is linked to coordinated social-media attacks after tweets by former health minister Aurélien Rousseau and criticism from doctors like Jérôme Marty.
Qu'est-ce que ça vous inspire exactement ce que l'on vit là avec l'enregistrement d'Anthony Fauci ?
Doyer says the recording confirms that authorities and doctors pressured people into vaccination without proper disclosure, and that many acted dangerously by deciding for patients without informing them.
N'ont-ils toujours pas pris connaissance de l'ensemble de ces contrats ?
Doyer says the French debate is behind the US, and that the contract documents will lead to more scrutiny and eventually trials.
Unlock the full claims, asset map, scores, related transcripts, follow-up questions, and AI chat — shaped around your portfolio, watchlist, favorite speakers, and risks.
